Question 1

What is the catalog number for CHO Monoclonal EGFR Antibody (modotuximab) - Chimeric - (Dry Ice)?

Accepted Answer

The catalog number for CHO Monoclonal EGFR Antibody (modotuximab) - Chimeric - (Dry Ice) is NBP3-27997-1mg.

Question 2

What sizes are available for CHO Monoclonal EGFR Antibody (modotuximab) - Chimeric - (Dry Ice)?

Accepted Answer

CHO Monoclonal EGFR Antibody (modotuximab) - Chimeric - (Dry Ice) is available in the following size(s): 1 mg.

Question 3

Is CHO Monoclonal EGFR Antibody (modotuximab) - Chimeric - (Dry Ice) in stock?

Accepted Answer

CHO Monoclonal EGFR Antibody (modotuximab) - Chimeric - (Dry Ice) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 5

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 6

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

CHO Monoclonal EGFR Antibody (modotuximab) - Chimeric - (Dry Ice)

Product Specifications

Frequently Asked Questions

Explore Other Products

CD54 (W-CAM-1; same as Wehi-CAM-1 or 1H4), CF740 conjugate, 0.1mg/mL

Melanoma Marker (PNL2), CF647 conjugate, 0.1mg/mL

HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF740 conjugate, 0.1mg/mL

CD79b (B-Cell Marker) (IGB/3170R), 0.2mg/mL

PAX2 (Renal Cell & Ovarian Carcinoma Marker) (PAX2/1104), CF405S conjugate, 0.1mg/mL

MMP3 (Marker of Metastasis and Rheumatoid Arthritis) (MMP3/1730), 0.2mg/mL